This forum is for questions about medical issues and research aspects of
Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new
Hepatitis Social/Living with Hepatitis forum
Also Vertex has bought a company that has inhibitors and will beging testing teleprevir and these inhibitors without interferon later this year. Fingers are crossed for success.
From: http://www.medscape.com/viewarticle/587261
Recent Developments in Specifically Targeted Small-Molecule HCV Therapies: Will Interferons Remain Indispensable? (Slides With Transcript)
Nezam H. Afdhal, MD Disclosures
"....So, the question that they asked me is what is going to happen to IFN when these new drugs come? I'm thoroughly convinced that at least for a period of time, IFN will act as the platform for most of our future combination therapies. It's hard to see that going, as it is hard to see ribavirin going anywhere fast. Viral enzyme inhibitors, you know hopefully they'll be a big yellow box with multiple different enzyme inhibitors here. And as Dr McHutchison will talk to you later, maybe if we can develop immunomodulators, we can change this paradigm, if in fact immunomodulators are necessary....."
PS, That is just my guess and hope I'm wrong and it is sooner